Norvia BioPartners — Global Biopharma Licensing & Supply Chain

Accelerating Global Biopharma Licensing and End-to-End Supply Chain Execution

Connecting life science innovators across the US, China, and global markets through seamless asset transactions, vetted CRO/CDMO sourcing, and reliable cross-border logistics.

In & Out-LicensingCDMO & Supply Chain LogisticsAntibodies, ADCs, TIDES & Small MoleculesVHH Discovery CRO

01 · Global Licensing

Global Asset Licensing & Deal Execution

In-licensing & out-licensing

Out-Licensing for APAC Innovators

Package preclinical and clinical assets into Western pharma-grade CIMs and data rooms, and connect directly with US/EU business development teams.

In-Licensing, Scouting & Due Diligence

Source differentiated, cost-effective biologics, ADCs, TIDES and small molecules from Asia for Western biotechs, backed by deep technical due diligence.

Scientific & CMC Due Diligence

Evaluate raw preclinical data, assay validity and manufacturing scalability.

IP Landscape Search & FTO Screening

Patentability assessment and freedom-to-operate risk review to ensure clean global rights.

Transaction Structuring

Maximize upfronts, milestone payments and royalties while securing clean global or ex-China rights.

02 · Supply Chain & Logistics

Biopharma Supply Chain, CRO/CDMO Sourcing & Logistics

From partner selection to delivery

Vetted CDMO & CRO Matchmaking

Connect with certified, high-capacity global and APAC partners across antibodies, ADCs, TIDES (oligonucleotides & peptides) and small molecules.

Cross-Border Logistics & Fulfillment

End-to-end management of biological material procurement, cold-chain transport, customs clearance and regulatory import/export compliance.

CMC & Quality Oversight

On-the-ground technical auditing and project management to ensure on-time, on-spec batch delivery.

03 · In-House CRO

Llama Immunization & VHH Humanization CRO

Scientific capability, in-house

Custom Immunization & Display Screening

Custom alpaca/llama immunization and phage & yeast display screening to generate high-affinity single-domain binders.

AI-Guided Precision Humanization

Retain sub-nanomolar affinity and superior thermal stability (Tm > 70°C) for rapid therapeutic development.

Multidisciplinary Leadership Built for Cross-Border Execution

Our work is driven by an integrated team uniting discovery science, frontline clinical experience, healthcare policy, and international transactional law. This cross-functional synergy ensures every licensing deal and CDMO supply chain project is evaluated from lab bench to bedside and commercial execution.

Discovery & Antibody Engineering (PhDs)

Deep expertise in immunology, camelid VHH engineering, display screening, ADCs, TIDES, and CMC scale-up.

Frontline Clinical Practice (RNs & RRTs)

Experienced Registered Nurses and Registered Respiratory Therapists offering real-world clinical insight into patient workflows, trial feasibility, and medical supply logistics.

Healthcare Policy & Management (MPH)

Public health specialists navigating regulatory strategy, market access, reimbursement dynamics, and healthcare policy.

Cross-Border Transactions & IP (LL.M.)

Specialists in International Business Transactions structuring airtight licensing terms, IP/FTO due diligence, and global CDMO contracts.